Literature DB >> 23949872

Vesiculopustular eruption in neonatal transient myeloproliferative disorder.

Iraz Nar1, Ozge Surmeli-Onay, Selin Aytac, Beril Talim, Pelin Ozlem Kiper, Koray Boduroglu, Murat Yurdakok.   

Abstract

Transient myeloproliferative disorder (TMD) typically presents with pancytopenia, hepatosplenomegaly, and immature circulating white blood cells, and affects approximately 10 % of neonates with Down syndrome. The authors report a neonate with Down syndrome who developed acute widespread pustular eruptions as a sign of TMD. The white blood cell counts on the first day of life were markedly elevated, with blasts seen on examination of the peripheral blood smear. And the patient was noted to have a few erythematous papules and pustules especially on the face. On the following days pathergy positive crusted papules and pustules were increased and spread to trunk and extremities. Skin biopsy specimens showed pustular dermatitis, with subcorneal vesiculopustules and perivascular inflammation in superficial dermis. These lesions improved parallel with the hematologic improvement within two weeks. The authors aim to alert clinicians about this uncommon cause of vesiculopustular eruption with the present illustrative case and review the literature.

Entities:  

Mesh:

Year:  2013        PMID: 23949872     DOI: 10.1007/s12098-013-1192-7

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  6 in total

1.  An unusual pustular eruption in an infant with Down syndrome and a congenital leukemoid reaction.

Authors:  L H Lerner; K Wiss; S Gellis; R Barnhill
Journal:  J Am Acad Dermatol       Date:  1996-08       Impact factor: 11.527

2.  Transient myeloproliferative disorder with vesiculopustular eruption: Early smear is useful for quick diagnosis.

Authors:  Hisashi Uhara; Masaaki Shiohara; Atsushi Baba; Junko Shiohara; Toshiaki Saida
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

3.  Vesiculopustular eruptions in Down syndrome neonates with myeloproliferative disorders.

Authors:  A Nijhawan; E Baselga; M A Gonzalez-Ensenat; A Vicente; J F Southern; B M Camitta; N B Esterly; B A Drolet
Journal:  Arch Dermatol       Date:  2001-06

Review 4.  Diagnosis and treatment of pustular disorders in the neonate.

Authors:  M C Van Praag; R W Van Rooij; E Folkers; R Spritzer; H E Menke; A P Oranje
Journal:  Pediatr Dermatol       Date:  1997 Mar-Apr       Impact factor: 1.588

Review 5.  Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.

Authors:  Anindita Roy; Irene Roberts; Alice Norton; Paresh Vyas
Journal:  Br J Haematol       Date:  2009-07-06       Impact factor: 6.998

6.  Treatment and prognostic impact of transient leukemia in neonates with Down syndrome.

Authors:  Jan-Henning Klusmann; Ursula Creutzig; Martin Zimmermann; Michael Dworzak; Norbert Jorch; Claudia Langebrake; Arnulf Pekrun; Katarina Macakova-Reinhardt; Dirk Reinhardt
Journal:  Blood       Date:  2008-01-08       Impact factor: 22.113

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.